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Synopsis 
The removal efficacy of the USEPA Contaminant Candidate List viruses is 
evaluated under enhanced coagulation conditions using varying FeCl3 doses 
and pH. 
Abstract 
Enhanced coagulation was evaluated for removal efficacy of coxsackievirus 
and echovirus (Contaminant Candidate List [CCL] enteroviruses), poliovirus, 
four potential surrogate bacteriophages, and dissolved organic carbon (DOC). 
Viruses and DOC were effectively removed using enhanced coagulation, with 
removals generally improving as dose increased and pH decreased. Optimal 
enhanced coagulation conditions of 40 mg/L FeCl3 and pH between 5 and 6.5 
resulted in a maximum removal of 3.0 logs of coxsackievirus B6, 1.75 logs of 
echovirus 12, 2.5 logs of poliovirus 1, 1.8 logs of fr, 1.3 logs of phi-X174, 
0.36 logs of MS2, 0.29 logs of PRD1, and 41% DOC. Bacteriophages fr and 
phi-X174 appear to be the most representative surrogates for the physical 
removal of coxsackievirus, while MS2 and PRD1 are more conservative. For 
echovirus, MS2 and PRD1 appear to be the most appropriate surrogates. The 
relative removal profiles of the enteroviruses (greatest removal of 
coxsackievirus followed by poliovirus and then echovirus) suggest that studies 
of the physical removal of poliovirus may be extended to the CCL 
enteroviruses. These results contribute to evaluations of the CCL and 
regulatory status of coxsackievirus and echovirus and aid in building a 
database of the treatment efficiencies of enteroviruses and their surrogates. 
Introduction 
In an effort to ensure the safety of the nation’s drinking water, 
the United States Environmental Protection Agency (USEPA) 
continually develops and re-evaluates regulations targeting drinking 
water contaminants. Recently promulgated regulations such as the 
Long-term 2 Enhanced Surface Water Treatment Rule (LT2) and the 
Disinfectants and Disinfection Byproduct Rule (DBPR) are shifting the 
focus of treatment processes such as coagulation in an attempt to 
simultaneously balance the risks posed by microbial and chemical 
contaminants. Strategies for mitigating contaminants of emerging 
concern, such as disinfection byproducts (DBPs), are specifically 
emphasized in these regulations. The removal of DBP precursors such 
as dissolved organic carbon (DOC) prior to disinfection is an effective 
means of limiting DBP formation. Enhanced coagulation using 
increased coagulant dose and/or pH adjustment was identified by the 
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DBPR as the best available technology for DOC removal (1). The Stage 
1 DBPR requires many systems using surface water, or groundwater 
directly under the influence of surface water, to implement enhanced 
coagulation.2 
 
Although substantial efforts have been devoted to assessing the 
removal of DBP precursors from drinking water using enhanced 
coagulation,1,3-5 limited information is available regarding the efficacy 
of enhanced coagulation for the removal of emerging pathogens.6-8 
Conventional coagulation, flocculation, and sedimentation processes 
have demonstrated efficiency in the removal of viruses, bacteria, and 
protozoa.9-11 Similar studies are needed to evaluate the effect of 
enhanced coagulation optimization for the reduction of DOC on the 
removal of emerging pathogens, such as those on the USEPA’s 
Contaminant Candidate List (CCL). The CCL is a list of currently 
unregulated contaminants warranting priority research since they are 
known or believed to occur in public water systems and may represent 
a public health risk. The current CCL (CCL 2, published in February 
2005) includes four viruses: adenovirus, calicivirus, coxsackievirus, 
and echovirus.12 The physical removal of adenovirus and calicivirus 
was examined in the companion study,7 while this study focused on 
the removal of coxsackievirus and echovirus under enhanced 
coagulation conditions. 
 
Although relatively limited data is available regarding the 
treatment of coxsackievirus and echovirus in drinking water systems, a 
great deal of information exists regarding the treatability of the 
prototype enterovirus, poliovirus. As the first virus propagated in 
tissue culture,13 poliovirus is perhaps the most recognized and widely 
studied of all viruses. Should similarities be observed between the 
removal profiles of the CCL viruses and poliovirus, it may be possible 
to extend studies of the removal of poliovirus to coxsackievirus and 
echovirus. Accordingly, poliovirus was also included in this study. 
 
In addition to the enteroviruses, bacteriophages MS2, PRD1, 
phi-X174, and fr were included as potential surrogates for the physical 
removal of coxsackievirus and echovirus. Bacteriophages share many 
similarities with human viruses (e.g., size, isoelectric point, etc., as 
shown in Table 1) but are faster, less expensive, and easier to assay 
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(7). Bacteriophages having removal profiles similar to those of the CCL 
viruses may be valuable surrogates for studies of enterovirus removal. 
The results of this study will aid in building a database of treatment 
efficacies of enteroviruses and their surrogates and in evaluating their 
CCL and regulatory status. 
 
Table 1. Virus Characteristics 
CCL virus cell line sizea(nm) 
isoelectric 
pointa 
genetic 
structure 
coxsackievirus (ATCC 
VR-155) 
buffalo green 
monkey kidney 
(BGM) 
24−30 b Single-
stranded RNA 
echovirus (ATCC VR-
1563) 
buffalo green 
monkey kidney 
(BGM) 
24−30 b Single-
stranded RNA 
poliovirus type 1c 
(strain Lsc-2ab) 
buffalo green 
monkey kidney 
(BGM) 
24−30 7.0−8.2 (A 
state)d 
Single-
stranded RNA 
          
bacteriophage bacterial host sizea(nm) isoelectric 
pointa 
genetic 
structure 
MS2(ATCC 15597-
B1) 
Escherichia coli (ATCC 
15597) 
24−27 3.5−3.9 single-
stranded RNA 
PRD1(ATCC BAA-
769-B1) 
Salmonella 
typhimurium LT2 (ATCC 
19585) 
62−65 3.0−4.2 double-
stranded DNA 
phi-X174(ATCC 
13706-B1) 
Escherichia coli (ATCC 
13706) 
23−27 6.6 single-
stranded DNA 
fr(ATCC 15767-B1) Escherichia coli (ATCC 
19853) 
19−23 8.9−9.0 single-
stranded RNA 
aAs summarized by Mayer, 20086 and Abbaszadegan, 20077. 
bDetermination of the isoelectric points of pathogenic viruses is very difficult, and few 
have been reported. The isoelectric points of coxsackievirus and echovirus have not 
yet been determined by empirical means. 
cPoliovirus is not a CCL virus, but it shares many similarities with coxsackievirus and 
echovirus, and it was included in this study for comparative purposes. 
dAs described by Mayer, 2008,6 some enteroviruses have two conformational states (A 
and B), each with its own isoelectric point. 
Materials and Methods 
Jar Testing  
 
A series of bench-scale jar tests was performed to optimize 
ferric chloride dose and pH with respect to DOC removal. To prevent 
interference between parameters, separate tests using identical 
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enhanced coagulation treatments were conducted to develop removal 
profiles for coxsackievirus, echovirus, poliovirus, the four 
bacteriophages, and DOC. Untreated central Arizona surface water of 
turbidity 9−22 NTU, pH 7−8, alkalinity 140−260 mg/L as CaCO3, and 
DOC 4 mg/L was used. A 10 L water sample (at 20 °C) was seeded 
with a known number of viruses (final concentration of 106 plaque 
forming units [PFU] per mL of each bacteriophage or 103.5 50% tissue 
culture infectious dose [TCID50] per mL of each enterovirus). A sample 
of the seeded water was collected for determination of initial virus 
concentrations. The water was distributed to a Phipps & Bird PB-700 
(Richmond, VA) jar test apparatus at a volume of 1.5 L per jar. Ferric 
chloride (ferric chloride hexahydrate lumps, Sigma Chemical Co., St. 
Louis, MO), cationic polymer (polydiallyldimethyl ammonium chloride 
[polyDADMAC], Clarifloc 350, Polydyne, Inc., Riceboro, GA), and 1 N 
HCl were immediately added, as described in the following paragraph. 
 
Ferric chloride was used in this study because it has 
demonstrated improved organic removal compared to alum.14 Doses 
are heavily dependent on water quality, and are therefore widely 
variable.15 Enhanced coagulation doses range from 5 to 150 mg/L 
FeCl3,14 but more commonly range from 20 to 60 mg/L FeCl3.4 In this 
study, coagulant doses ranging from 20 to 120 mg/L FeCl3 were tested 
in increments of 20 mg/L in an effort to optimize coagulant dose. 
Variations in polymer dose have not demonstrated a significant effect 
on DOC removal during enhanced coagulation;1 therefore, polymer 
was applied at a constant dose of 0.4 mg/L. At the previously 
determined optimal coagulant dose, pH adjustment was evaluated in 
order to identify the optimal pH. Coagulation of natural organic matter 
with ferric chloride is typically optimized at a pH of approximately 
4−5;3,5 however, for practical reasons, enhanced coagulation is 
generally carried out in a pH range of 5−7.1 At the optimal coagulant 
dose, target pH values ranging from 5.5 to 7.0 were tested using 
increments of 0.5 as part of this investigation. 
 
Immediately following chemical addition, the jars were mixed at 
100 rpm for 1 min, 40 rpm for 10 min, 20 rpm for 10 min, and no 
mixing for 30 min, as described by Volk et al.4 Samples were assayed 
for bacteriophages or enteroviruses, DOC, pH, turbidity, and ultraviolet 
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absorbance at a wavelength of 254 nm (UV254), all of which have the 
potential to affect the efficacy of coagulation. 
 
Virus Propagation and Assays  
 
Bacteriophages MS2 (ATCC 15597-B1), phi-X174 (ATCC 13706-
B1), fr (ATCC 15767-B1), and PRD1 (ATCC BAA-769-B1) and their 
respective bacterial hosts E. coli (ATCC 15597, 13706, and 19853) and 
S. typhimurium LT2 (ATCC 19585) were obtained from the American 
Type Culture Collection (ATCC, Rockville, MD). Bacteriophage stocks 
were propagated using the double agar layer (DAL) method.16 The 
bacteriophages were eluted from the plates using 10 mL of buffered 
demand free (BDF) water (0.54 g Na2HPO4 and 0.88 g KH2PO4 per liter 
of nanopure water, pH 7.0). The supernatant was collected and 
centrifuged at 4 °C at 1200g for 15 min to remove bacteria. To 
minimize DOC content, the stocks were purified using two successive 
polyethylene glycol (PEG) precipitations followed by a Vertrel XF (Micro 
Care Marketing Services, New Britain, CT) extraction and resuspension 
in BDF, as described by Thurston-Enriquez et al.17 Briefly, the 
suspension was augmented with 9% PEG (MW 8000) and 1 M NaCl 
and was allowed to stir overnight at 4 °C. It was then centrifuged at 
4 °C at 8000g for 90 min. The supernatant was discarded, and the 
pellet was resuspended in 10% of its original volume of BDF water. To 
remove lipids and facilitate the monodispersion of viruses, a Vertrel XF 
extraction was performed by centrifuging a suspension of equal parts 
Vertrel and virus at 4 °C at 8000g for 90 min.17 The supernatant 
containing the purified viruses (typically on the order of 1010 PFU/mL) 
was stored at 4 °C. 
 
Coxsackievirus B6 Schmitt (ATCC VR-155) and echovirus 12 
Travis (ATCC VR-1563) were obtained from the ATCC. Poliovirus type 
1 (attenuated strain Lsc-2ab) was kindly provided by Dr. Charles P. 
Gerba of the University of Arizona. All viruses were cultured using 
conventional in vitro cell culture techniques in a continuous buffalo 
green monkey kidney (BGM) cell line in 1X Eagle’s minimum essential 
medium (MEM) containing 5% fetal bovine serum (FBS). For virus 
propagation, the cells were inoculated with approximately 1 × 106 
TCID50/mL of virus and incubated at 37 °C until at least 90% infected. 
Three freeze/thaw cycles were used to facilitate the release of the 
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virus particles. The supernatant was collected and centrifuged at 4 °C 
at 1200g for 15 min to remove cellular debris. Virus stocks were 
purified using two successive PEG precipitations, a Vertrel XF 
extraction, and resuspension in BDF water, as described previously. 
The purified viruses (typically on the order of 106 TCID50/mL) were 
stored at × 80 °C. 
 
Immediately following jar test experiments, the water samples 
were serially diluted (10-fold) in BDF water (sufficient for up to 5-log 
removal of bacteriophages and 3.5-log removal of enteroviruses). The 
bacteriophages were assayed in triplicate using the DAL method,16 and 
the enteroviruses were assayed using conventional in vitro cell culture 
techniques. Positive and negative controls were included in each set of 
assays. For cell culture, BGM cells were grown in 24-well trays. Each 
sample dilution was used to inoculate four wells, using 0.1 mL of 
sample per well. The trays were incubated in a 5% CO2 incubator at 
37 °C and were examined daily for up to 14 days for cytopathogenic 
effects (CPE) in the form of cell enlargement, rounding, and 
detachment. The Karber TCID50 method was used to quantify the viral 
concentration of each sample, as described by Abbaszadegan et al.7 
The log reduction of bacteriophages and enteroviruses (−log[Nt/N0], 
where Nt is the number of viruses in the treated sample and N0 is the 
number in the original sample) was calculated for each enhanced 
coagulation treatment condition. 
 
Chemical Parameter Analysis  
 
The pH was measured using a Mettler (Columbus, OH) pH 
meter. Turbidity was measured using a Hach (Loveland, CO) model 
2100P turbidimeter. For DOC determination, samples were filtered 
using 1.2 μm Whatman (Middlesex, UK) GF/C glass microfiber filters, 
acidified using 1 N HCl, and analyzed using a Shimadzu 5050A (Kyoto, 
Japan) total organic carbon analyzer. A Shimadzu Multispec 1501 was 
used to measure UV254. UV254 was used to calculate specific UV 
absorbance (SUVA = UV254/DOC, [L(mg × m)−1]), which is sometimes 
used as a surrogate measurement of DBP precursors.14 
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Statistical Analysis  
 
Statistical analyses were performed to determine if the mean 
bacteriophage removals resulting from different treatment conditions 
were statistically different at a significance level of α = 0.05. SPSS 
(Chicago, IL) Version 12.0 statistical software was used to compute 
the Levene statistic, analysis of variance (ANOVA), Welch test, Tukey’s 
honestly significant difference (HSD) test, and the Games-Howell test, 
as described by Abbaszadegan et al.7 Statistics were also used to test 
for correlations between virus removals and their respective isoelectric 
points and sizes. Using Microsoft Excel, Pearson product moment 
correlations (as described by Karl Pearson in 1895)18 and linear 
regression models were computed and used to evaluate the 
relationship between the variables. 
Results and Discussion 
Coagulant Dose Optimization Jar Tests  
 
The coagulant dose optimization jar tests (performed without pH 
adjustment) demonstrated that bacteriophage removal generally 
increased as coagulant dose increased (Figure 1). Overall, fr was 
removed to the greatest extent, followed by phi-X174, PRD1, and 
MS2. Statistical analyses were performed using the mean log removals 
of the bacteriophages (n = 3) at different coagulant doses to 
determine the optimal dose required to produce significant virus 
removal. For each of the four bacteriophages, there was a significant 
difference between log removals at different coagulant doses (P ≤ 
0.05), as shown in Table 1 in the Supporting Information. The optimal 
dose for the removal of each bacteriophage (as summarized in Table 
2) was identified as the lowest dose at which a significant 
improvement in removal was observed with incremental increases in 
coagulant dose (P ≤ 0.05), but beyond which, removals did not 
significantly improve. The results of the statistical analyses are 
provided in Table 2 in the Supporting Information. 
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Figure 1. Removal of microbes and DOC as a function of FeCl3 dose in the first jar 
test. The error bars represent ±1 standard deviation for the bacteriophages and ±5% 
for the enteroviruses and DOC. 
Table 2. Summary of Optimal Treatment Conditions 
variable coagulant dose (mg/L FeCl3) pH (at 40 mg/L FeCl3) 
MS2 60 <6.5 
PRD1 ≥100   
phi-X174 100 6.0 
fr 40 <6.5 
coxsackievirus 100−120 (first test); 60 (2nd test) <6.5 
(1st test); < 6.0 (2nd test) 
echovirus 120 (1st test); 60 (2nd test) <7.0 (1st test); < 6.0 (2nd test) 
poliovirus 120(1st test); 60 (2nd test) <5.5 
DOC 100 (1st test); 60 (2nd test) <6.5 
overall 
recommendation 
40 <6.5 
 
Due to the time- and material-intensive nature of the in vitro 
cell culture assay, one replicate was analyzed for each of the two 
independent enterovirus experiments. Since water quality varied 
between tests, they were not considered replicates, and statistical 
analyses were not employed to determine the optimal coagulant dose 
for enterovirus removal. However, the data in Figure 1 (for the first 
virus test) indicate that although some improvement in enterovirus 
removal was observed at low coagulant doses, consistent 
improvements were achieved only at the high end of the dose range. 
Based on the results of the first test, a second enterovirus jar test was 
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performed, thereby providing a second independent data set. For the 
second test, the coagulant dose range was narrowed to 20, 40, and 60 
mg/L FeCl3, based on improved performance and practicality under 
these conditions, as indicated by the results of the bacteriophage and 
first CCL virus test results. The results of the second test are shown in 
Figure 2. Again, they suggest that enterovirus removal improves 
throughout the dose range tested. Relative to one another, 
coxsackievirus B6 (CoxB6) was consistently removed to the greatest 
extent, followed by poliovirus 1 (Polio1), and then echovirus 12 
(Echo12). 
 
 
Figure 2. Removal of microbes and DOC as a function of FeCl3 dose in the second jar 
test. The error bars represent ±5%. 
CoxB6 was consistently removed to a greater extent than phi-
X174, PRD1, and MS2. This suggests that these microbes may be 
acceptable surrogates for CoxB6 since the treatment required for their 
removal would remove CoxB6 to an even greater extent. The removal 
of phi-X174 was more similar to that of CoxB6, suggesting that phi-
X174 would be more representative, while MS2 and PRD1 would be 
more conservative surrogates since they were removed to a lesser 
extent. The removal profile of bacteriophage fr was most similar to 
CoxB6; however, its suitability as a surrogate was questionable since it 
was sometimes removed more efficiently than CoxB6. Echo12 was 
consistently removed to a lesser extent than CoxB6, and was also 
generally removed to a lesser extent than bacteriophages fr and phi-
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X174. This indicates that fr and phi-X174 would not be suitable 
surrogates, while MS2 and PRD1 may be appropriate surrogates since 
they were removed to a similar, but lesser extent than Echo12. 
 
Coagulation processes typically target the removal of organic 
matter, such as DOC, whereas virus removal is considered an ancillary 
benefit. Accordingly, optimal coagulant doses are generally selected on 
the basis of DOC removal, regardless of the optimal dose range for 
virus removal. The USEPA’s Enhanced Coagulation Guidance Manual2 
requires a 25% reduction in DOC to satisfy the enhanced coagulation 
requirements for this source water (total organic carbon of 4.0−8.0 
mg/L and alkalinity >120 mg/L as CaCO3). This condition was satisfied 
using doses of 100−120 mg/L FeCl3 (Table 3). In this range, 
substantial decreases in turbidity, UV254, and SUVA (all measures of 
the efficacy of coagulation) were also observed. For enhanced 
coagulation, the optimal coagulant dose is defined as the point of 
diminishing return (PODR).2 The PODR is the dose at which the change 
in DOC removal divided by the change in coagulant addition drops to 
(and subsequently remains below) 0.03.2 Using the PODR criteria, the 
optimal dose for DOC removal was 100 mg/L FeCl3 in the first test and 
60 mg/L FeCl3 in the second test. These doses exceed those typically 
used at water treatment facilities, but can be reduced using pH 
adjustment to improve DOC removal. Consequently, pH optimization 
tests were performed using a more moderate coagulant dose of 40 
mg/L FeCl3 and pH adjustment, as described in the following section. 
 
Table 3. Chemical Parameters for Jar Tests 
FeCl3dose 
(mg/L) 
pH 
DOC 
(mg/L) 
DOC% 
removal) 
Δ 
DOC/Δ 
dose 
turbidity 
(NTU) 
UV254 
(cm-1) 
SUVA 
(L/(mg × 
m)) 
bacteriophage and first CCL virus jar test 
0 8.10 4.24     9.18 0.090 2.1 
20 7.04 3.93 7.3% 0.02 1.87 0.061 1.6 
40 6.92 3.97 6.4% 0.00 2.04 0.044 1.1 
60 6.51 3.61 14.9% 0.02 1.24 0.032 0.9 
80 6.35 3.29 22.4% 0.02 1.18 0.027 0.8 
100 6.11 2.60 38.7% 0.03 1.61 0.021 0.8 
120 6.03 2.38 43.9% 0.01 1.27 0.018 0.8 
40 7.0 3.97 6.4%   0.61 0.044 1.1 
40 6.5 3.50 17.5%   0.65 0.042 1.2 
40 6.0 2.76 34.9%   0.71 0.033 1.2 
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FeCl3dose 
(mg/L) 
pH 
DOC 
(mg/L) 
DOC% 
removal) 
Δ 
DOC/Δ 
dose 
turbidity 
(NTU) 
UV254 
(cm-1) 
SUVA 
(L/(mg × 
m)) 
40 5.5 2.49 41.3%   0.73 0.025 1.0 
second CCL virus jar test 
0 7.15 4.54     22.2 0.075 1.6 
20 6.82       2.83 0.063   
40 6.53 4.20 7.5%   1.43 0.047 1.1 
60 6.28 4.10 9.7% 0.01 1.04 0.040 1.0 
40 6.0 3.46 7.5%   1.43 0.047 1.1 
40 5.5 3.45 24.0%   0.69 0.030 0.9 
 
pH Optimization Jar Tests  
 
For the pH optimization jar tests (as in the dose adjustment jar 
tests), bacteriophage fr was generally removed to the greatest extent, 
followed by phi-X174, MS2, and PRD1 (Figure 3). Overall, 
bacteriophage removal improved slightly in response to reductions in 
pH. The removals of MS2, phi-X174, and fr demonstrated significant 
improvement as pH incrementally decreased from 8.0 to 5.5 (P ≤ 
0.05), whereas PRD1 removal did not improve significantly (Table 3 in 
the Supporting Information). Statistical analyses were performed using 
the mean log removals of the bacteriophages at different pH values to 
determine the optimal pH required to produce significant virus 
removal. The optimal pH (as summarized in Table 2) was identified as 
the highest pH at which significant improvement in removal was 
observed as pH decreased, but beyond which, significant 
improvements were not observed. The results of the statistical 
analyses are provided in Table 4 in the Supporting Information. 
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Figure 3. Removal of microbes and DOC as a function of pH adjustment at a 
coagulant dose of 40 mg/L FeCl3 in the first jar test. The error bars represent ±1 
standard deviation for the bacteriophages and ±5% for the CCL viruses and DOC 
removals. 
Figures 3 and 4 illustrate that enterovirus removals generally 
improved as the pH decreased, although statistical analyses could not 
be employed to verify this observation, as described previously. For 
the first virus test (Figure 3), the removal of CoxB6 improved as the 
pH decreased from 7.0 to 6.5, and again as pH decreased to 6.0. No 
additional removal was observed when the pH was decreased to 5.5, 
thereby suggesting an optimal pH for CoxB6 removal of less than 6.5. 
For Echo12, no additional removal was observed for pH adjustments 
below 6.5, thereby indicating that pH values less than 7.0 were 
optimal. The removal of Polio1 appeared to improve with each 
incremental reduction in pH. Based on these results, a second virus 
test was performed at pH values of 6.5, 6.0, and 5.5 (Figure 4). The 
second test again suggested that virus removal improved as the pH 
decreased. As in the dose optimization tests, CoxB6 was removed to a 
greater extent than Polio1, followed by Echo12. The consistency of the 
relative removal profiles of the enteroviruses suggests that studies of 
the physical removal of poliovirus may be extended to the CCL 
enteroviruses, which may contribute to evaluations of their CCL and 
regulatory status. 
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Figure 4. Removal of microbes and DOC as a function of pH adjustment at a 
coagulant dose of 40 mg/L FeCl3 in the second jar test. The error bars represent ±5%. 
CoxB6 was consistently removed to a greater extent than 
bacteriophages phi-X174, PRD1, and MS2, and also exceeded fr 
throughout most of the pH range tested. This suggests that the 
bacteriophages may be acceptable surrogates for CoxB6. The removals 
of fr and phi-X174 were the most similar to CoxB6, suggesting that 
they would be more representative surrogates, whereas MS2 and 
PRD1 would be more conservative surrogates since they were removed 
to a lesser extent. Echo12 was consistently removed to a lesser extent 
than CoxB6. It was also removed to a lesser extent than bacteriophage 
fr, indicating that fr would not be a suitable surrogate. Although 
Echo12 was removed to a greater extent than phi-X174 for most of 
the pH range, phi-X174 was removed to a greater extent at pH 5.5. 
Thus, the suitability of phi-X174 as a surrogate for Echo12 was 
questionable. Regardless, MS2 and PRD1 were consistently removed to 
a lesser extent than Echo12, thereby indicating that they may be 
appropriate surrogates. 
 
The pH optimization jar tests satisfied the USEPA enhanced 
coagulation guidelines2 by achieving at least 25% DOC removal below 
pH 6.5 in the first test (Table 3). Decreases in pH also resulted in 
decreases in UV254 and SUVA. Although an optimal pH cannot be 
determined using the PODR calculation, as done to optimize dose 
(since the PODR is calculated relative to coagulant dose increments), 
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the data suggests that the optimal pH range is less than 6.5 based on 
improved DOC removal in this pH range. Practical limitations 
effectively impart a lower pH boundary of 5;3 thus, the optimal pH 
range for DOC removal was 5.0−6.5. 
 
Virus Removal Mechanisms  
 
The quantification of virus removal during physical and chemical 
separation processes is well documented.19-21 The main mechanism for 
the physical removal of viruses appears to be adsorption and charge 
neutralization followed by gravitational separation; however, the 
details of virus adsorption during coagulation and flocculation are not 
yet fully understood. Studies of transport through soil matrices have 
reported that the adsorption of viruses is a complex process in which 
hydrophobicity, surface charge, and isoelectric point (pI) are influential 
factors.22,23 While it appears that no individual factor can adequately 
explain the mechanism of virus adsorption, pI has been suggested to 
be the dominant factor controlling virus adsorption during transport 
through sandy soils.22 The complete effects of the addition of 
coagulant, specifically on the surface charge of the virus, are not fully 
understood, but the pI may help to explain adsorption during 
coagulation. 
 
The pI of fr is relatively high (Table 1), meaning that its surface 
is positively charged in pH ranges encountered during coagulation (5–
8), whereas MS2 and PRD1 would be negatively charged and phi-X174 
may be either. For negatively charged particulate matter, the 
bacteriophage pIs generally support the observed removal trend (fr > 
phi-x174 > PRD1 > MS2). The relatively high stability (low physical 
removal) of MS2 is consistent with previous studies of filtration.24 
Relative to the other viruses, the pI of poliovirus is more similar to fr, 
perhaps suggesting that poliovirus removal would more closely 
resemble fr removal compared to the other bacteriophages. This 
hypothesis appears to be supported by the data shown in Figures 1 
and 3. Pearson correlation coefficients and linear regression models 
were used to evaluate the linear relationship between virus removal 
and their respective pIs and sizes (averages from Table 1). The 
statistics were computed separately for each treatment condition (jar 
test, coagulant dose/pH tested) to eliminate extraneous factors that 
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would affect microbial removal other than their physical 
characteristics. This essentially “leveled the field” so that the 
relationship between the variables was evaluated for a given water 
matrix and level of treatment. The results (Table 5 in the Supporting 
Information) indicated that virus removal was strongly correlated to 
isoelectric point (−0.05 < Pearson <0.0525 and R2 > 0.80), but the 
relationship between virus removal and size was not nearly as strong. 
Thus, while the exact mechanisms of adsorption cannot be identified 
as a result of this study, the results suggest that pI plays a role in 
virus removal by adsorption. 
Summary 
At a coagulant dose of 40 mg/L FeCl3 and a pH below 6.5, the 
USEPA criteria was satisfied by removing more than 25% of DOC. 
Under these enhanced coagulation conditions, a maximum removal of 
3.0 logs of CoxB6, 1.75 log of Echo12, 2.5 logs of Polio1, 1.8 logs of fr, 
1.3 logs of phi-X174, 0.36 logs of MS2, 0.29 logs of PRD1, and 41% 
DOC was observed. Viral isoelectric points appear to heavily influence 
the efficacy of removal by coagulation processes. Overall, CoxB6 was 
removed more efficiently than the bacteriophages, indicating that they 
may be suitable surrogates, with fr and phi-X174 being more 
representative and MS2 and PRD1 being more conservative. 
Bacteriophages MS2 and PRD1 appear to be the most suitable 
surrogates for Echo12. The relative removal profiles of the 
enteroviruses (greatest removal of coxsackievirus followed by 
poliovirus and then echovirus) suggest that studies of the physical 
removal of poliovirus may be extended to the CCL enteroviruses, 
which may contribute to evaluations of their CCL and regulatory 
status. 
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